Novel topical antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: tobra-a multicenter RCT...new grant, signed 9/19/2019, effective 9/30/2019,…

Ended Project Grant Awarded Last action

Award ID
W81XWH1910848
Recipient
Awarding agency
Obligated
$2,992,023

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Baltimore, MD 21201, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Novel topical antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: tobra-a multicenter RCT...new grant, signed 9/19/2019, effective 9/30/2019, distributed 9/20/2019, faadc 9/20/2019

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $2,992,023

Subawards

Subrecipient Amount Awarded
ST. Mary's Medical Center, Inc. Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $42,500
Vanderbilt University Medical Center Novel Tropical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA. $51,000
Dartmouth-Hitchcock Clinic Novel Tropical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA $21,250
Wake Forest University Health Sciences Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $21,250
Corewell Health $107,520
University Of Texas Health Science Center At Houston Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT $85,000
University Of Southern California Subrecipient is being contracted to screen and enroll patients into the TOBRA trial based on the specific eligibility criteria defined in the trial protocol. $8,500
University Of Mississippi Medical Center Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractions at High Risk of Infection: TOBRA - A Multicenter RCT $63,750
University Of Alabama At Birmingham Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT $51,000
Inova Health Care Services Novel Tropical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA $42,500
The University Of Kentucky Research Foundation study site TOBRA study $55,250
The Johns Hopkins University Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $188,319
University Of Wisconsin System Compare the effect of vancomycin powder (control) to vancomycin and tobramycin powder combined (treatment) in the reduction of post-fixation infections of the… $46,785
Yale Univ Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT $42,500
University Of Oklahoma $34,000
The Ohio State University Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $42,500
Texas TECH University Health Sciences Center $42,500
University Of North Carolina At Chapel Hill Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT $42,500
Baylor Research Institute Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $42,500
The Trustees Of The University Of Pennsylvania Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT $32,500
University Of Florida Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $42,500
The Johns Hopkins University $188,319
University Of Utah Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. Sub… $51,000
University Of Alabama At Birmingham Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. $36,680
The University Of Texas Health Science Center At San Antonio Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT; The… $31,122
Temple University-Of The Commonwealth System Of Higher Education Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter RCT. The… $51,513
Show all 26

Quick answers

Who received award W81XWH1910848?

W81XWH1910848 was awarded to University Of Maryland, Baltimore by Defense Health Agency (Department of Defense) on September 30, 2019.

How much is award W81XWH1910848 worth?

$2,992,023 has been obligated on W81XWH1910848.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login